Molecules 2017, 22, 1591
6 of 9
(GDH) were overproduced in E. coli BL21(DE3) strains harbouring a specific plasmid prepared
as previously reported: pET30a-OYE1 from the original plasmid provided by Neil C. Bruce [27],
pET30a-OYE2 and pET30a-OYE3 from S. cerevisiae BY4741 and pKTS-GDH from B. megaterium
DSM509 [28]; pDJBx-OYE2.6, pDJB5-OYE1-W116V, and pDJBx-LeOPR1 from the original plasmids
provided by Prof. Jon D. Stewart. For YqjM, the original plasmid provided by Prof. M. Hall was used
directly as provided [29]. The enzymes were produced and purified as described in Section 4.2.
4
.2. Overproduction of Enzymes in E. coli BL21(DE3)
LB medium (5 mL) containing the appropriate antibiotic (50
·
mL 1 kanamycin for pET30a,
−
µg
−
1
−1
1
00
µ
g
·
mL ampicillin for pKTS, pDJBx, 30
µ
g mL chloramphenicol for YqjM) was inoculated with
◦
a single colony from a fresh plate and grown for 8 h at 37 C and 220 rpm. This starter culture was
used to inoculate 200 mL LB medium (TB medium in the case of YqjM), which was incubated for 8 h
◦
under the same conditions and used to inoculate 1.5 L medium. The latter culture was shaken at 37 C
and 220 rpm until OD6 reached 0.4–0.5, then enzyme expression was induced by the addition of
00
−
1
0
.1 mM IPTG (50 ng mL anhydrotetracycline was also added in the case of the pKTS-GDH plasmid).
·
In the case of OYE1-3, GDH, and YqjM, after 5–6 h the cells were harvested by centrifugation
◦
(5000
×
g, 20 min, 4 C), resuspended in 50 mL of lysis buffer (20 mM KP buffer pH 7.0, 300 mM
NaCl, 10 mM imidazole) and disrupted by sonication (Omni Ruptor 250 ultrasonic homogeniser, Omni
International Inc., Kennesaw, GE, USA, five sonication cycles, 15 s each, 50% duty). YqjM was used
i
as cell-free extract, whereas for OYE1-3 and GDH the cell-free extract after centrifugation (20,000
×
g,
◦
2
0 min, 4 C) was chromatographed on IMAC stationary phase (Ni-Sepharose Fast Flow, GE Healthcare,
Little Chalfont, UK) with a mobile phase composed of 20 mM KP buffer pH 7.0, 300 mM NaCl, and
i
a 10–300 mM imidazole gradient. Protein elution was monitored at 280 nm, and the fractions were
collected according to the chromatogram and dialysed twice against 1.0 L of 50 mM KP buffer pH 7.0
i
◦
◦
80 C.
(
12 h each, 4 C) to remove imidazole and salts. Purified protein aliquots were stored frozen at
In the case of OYE2.6 and LeOPR1—produced as Glutathione S-transferase (GST)-fusion
proteins—cell pellets were resuspended in cold sepharose binding buffer (PBS, 140 mM NaCl, 2.7 mM
KCl, 10 mM Na HPO , 1.8 mM KH PO , pH 7.3) and lysed by sonication (Omni Ruptor 250 ultrasonic
−
2
4
2
4
homogeniser, five sonication cycles, 15 s each, 50% duty). The cell-free extract was centrifuged
◦
(
12,000 rpm, 40 min, 4 C). The resulting supernatant was passed through Glutathione Sepharose
4
Fast Flow (GE Healthcare), with PBS buffer as the mobile phase. Once the absorbance (280 nm)
returned to a baseline reading, the desired protein was eluted by adding a reduced glutathione (GSH)
buffer solution (10 mM -L-glutamyl-L-cysteinylglycine, 50 mM Tris-HCl, pH 8.0). Protein elution was
γ
monitored at 280 nm and the fractions were collected according to the chromatogram. Purified protein
◦
aliquots were stored frozen at −80 C.
4
.3. One-Pot Conversion of 2 into the Four Stereoisomers of 1
A solution of unsaturated ketone (100 mg, 0.794 mmol) in DMSO (500
potassium phosphate buffer solution (100 mL, 50 mM, pH 7.0) containing the suitable OYE (10–15 mg)
2
µL) was added to a
(
two batches with OYE2.6 and two batches with OYE1-W116V), glucose (4 eq., 3.18 mmol, 572 mg),
+
GDH (125 U), and NADP (0.025 eq., 20
an orbital shaker at 30 C. The intermediates (R) and (S)-
µmol, 15 mg). The reactions were incubated for 24 h in
◦
3
(ee = 99% and 92%, respectively, in both
batches) were not isolated, and were submitted to carbonyl reduction. ADH440 or ADH270 (5 mg,
two batches each), glucose (1 eq., 0.794 mmol, 143 mg), and GDH (125 U) were added to the four
◦
reaction mixtures. After 24 h incubation at 30 C, the final products were recovered and purified by
column chromatography, eluting with hexane and increasing quantities of EtOAc.
4
.3.1. (3R,4R)-4-Methylheptan-3-ol ((3R,4R)-1)
From
2
(100 mg, 0.794 mmol), after reduction with OYE2.6 and ADH270, compound (3R,4R)-
1
1
(
85.7 mg, 83%) was obtained: ee = 99% (chiral GC), de = 99% ( H-NMR); [
α
]D = + 23.0 (c 1.2, hexane)